79388821

Information

  • Trademark
  • 79388821
  • Serial Number
    79388821
  • Filing Date
    September 22, 2023
    a year ago
  • Transaction Date
    October 07, 2024
    3 months ago
  • Status Date
    October 07, 2024
    3 months ago
  • Location Date
    October 07, 2024
    3 months ago
  • Status Code
    661
  • Current Location
    TMO LAW OFFICE 131- EXAMINING ATTORNEY ASSIGNED
    Employee Name
    NICHOLSON, CIERRIA
  • Attorney Docket Number
    17113.212IB
    Attorney Name
    Andrew S. Ehard
    Law Office Assigned Location Code
    O40
  • Owners
Mark Drawing Code
2
Case File Statements
  • GS0401: Custom manufacture of pharmaceuticals, namely, radiopharmaceuticals; Custom manufacture of pharmaceuticals, namely, radiolabelling of pharmaceuticals
  • DM0000: The mark consists of a four point blue star in the center of a partially closed blue circle that contains openings on the top left and the bottom right. There are three blue shaded circles coming from the top left of the star and the bottom right of the star going out the top left of the circle and the bottom right of the circle in a line. The color white serves as background areas and is not claimed as a feature of the mark.
  • GS0051: Chemicals for pharmaceutical use in the nature of chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer and diseases associated with cellular proliferation; pharmaceutical drugs for the treatment of cancer and diseases associated with cellular proliferation; Pharmaceutical preparations for the treatment of cancer and diseases associated with cellular proliferation; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products, namely, radiopharmaceutical diagnostic preparations and radiopharmaceutical treatment preparations for the treatment of cancer and diseases associated with cellular proliferation; chemicals for radiopharmaceuticals for diagnostic uses; radiopharmaceutical drugs for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radiopharmaceutical products for diagnostic uses; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; radioactive elements, isotopes, preparations and reagents for radioactive labelling of pharmaceutical products; Diagnostic radiopharmaceutical preparations
  • GS0351: Advertising services; business advisory services relating to product development; business consultancy; retail and wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; intermediary business services relating to the commercialization of goods, namely, procuring of contracts for third parties for the purchase and sale of goods
  • GS0011: Radioactive elements for scientific purposes; radioactive preparations for scientific purposes; chemicals for use in the manufacture of radiopharmaceutical products; chemical products for radioactive labelling
  • GS0451: Exploitation of intellectual property rights, namely, licensing of intellectual property rights; licensing of intellectual property
  • GS0101: Apparatus for administering pharmaceuticals for the treatment, prevention, or diagnosis of cancer, namely, medical apparatus for introducing pharmaceutical preparations into the human body for the treatment, prevention, or diagnosis of cancer; apparatus for medical purposes for the treatment, prevention, or diagnosis of cancer, namely, injection needles, injection syringes, and radiological apparatus for the treatment, prevention, or diagnosis of cancer; medical apparatus for the treatment of cancer; diagnostic imaging apparatus for medical use; pharmaceutical instruments, namely, radiological apparatus for medical purposes, medical apparatus for the treatment of cancer and diseases associated with cellular proliferation, and imaging apparatus for medical use for diagnosing medical conditions; applicators for pharmaceutical preparations, namely, applicators for pharmaceutical preparations sold without medication
  • GS0421: Provision of scientific information in the field of pharmaceuticals and clinical trials; scientific and technical analysis, namely, scientific research analysis in the field of pharmaceuticals; scientific consultancy; scientific research; scientific research in the field of pharmacy; medical research; research and development of products; laboratory research relating to pharmaceuticals; advisory services being product development consultation relating to immunological products; research and development of new techniques for radiolabelling of pharmaceutical products
Case File Event Statements
  • 2/9/2024 - 11 months ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 2/16/2024 - 11 months ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/20/2024 - 10 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/21/2024 - 10 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 4/9/2024 - 9 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 5/1/2024 - 8 months ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/12/2024 - 11 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/14/2024 - 10 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/9/2024 - 9 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 10/7/2024 - 3 months ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/7/2024 - 3 months ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/7/2024 - 3 months ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA